{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:12:54Z","timestamp":1778145174768,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000690","name":"Research Councils UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_17136"],"award-info":[{"award-number":["MC_PC_17136"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuropharm.2025.110455","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:32:07Z","timestamp":1743946327000},"page":"110455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons"],"prefix":"10.1016","volume":"273","author":[{"given":"Victoria","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-3172","authenticated-orcid":false,"given":"Bruno G.","family":"Frenguelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-3970","authenticated-orcid":false,"given":"Richard T.","family":"Ngomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-8748","authenticated-orcid":false,"given":"Emily","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-1867","authenticated-orcid":false,"given":"Mark J.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110455_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.822499","article-title":"Alzheimer's disease enhanced tonic inhibition is correlated with upregulated astrocyte GABA transporter-3\/4 in a knock-in APP mouse model","volume":"13","author":"Aldabbagh","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2006.03.060","article-title":"Unique presynaptic and postsynaptic roles of Group II metabotropic glutamate receptors in the modulation of thalamic network activity","volume":"141","author":"Alexander","year":"2006","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110455_bib3","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","article-title":"NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation","volume":"103","author":"Amadoro","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110455_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110455_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2010.00049","article-title":"Intracellular and extracellular tau","volume":"4","author":"Avila","year":"2010","journal-title":"Front. Neurosci."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110455_bib7","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1021\/acsnano.3c01393","article-title":"Simultaneous determination of the size and shape of single \u03b1-synuclein oligomers in solution","volume":"17","author":"Awasthi","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110455_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1152\/jn.01107.2007","article-title":"Dynamic I-V curves are reliable predictors of naturalistic pyramidal-neuron voltage traces","volume":"99","author":"Badel","year":"2008","journal-title":"J. Neurophysiol."},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2025.110455_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00422-008-0259-4","article-title":"Extracting non-linear integrate-and-fire models from experimental data using dynamic I-V curves","volume":"99","author":"Badel","year":"2008","journal-title":"Biol. Cybern."},{"key":"10.1016\/j.neuropharm.2025.110455_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1137\/141000671","article-title":"Julia: a fresh approach to numerical computing","volume":"59","author":"Bezanson","year":"2017","journal-title":"SIAM Rev."},{"issue":"Suppl. 412 9","key":"10.1016\/j.neuropharm.2025.110455_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1528-1167.2005.00311.x","article-title":"Cellular and network mechanisms of spike-wave seizures","volume":"46","author":"Blumenfeld","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2025.110455_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnins.2018.00330","article-title":"Sleep disorders associated with Alzheimer's disease: a perspective","volume":"12","author":"Brzecka","year":"2018","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-023-01562-5","article-title":"Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations","volume":"11","author":"Brown","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2025.110455_bib14","series-title":"Rhythms of the Brain","author":"Buzs\u00e1ki","year":"2006"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110455_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yebeh.2012.11.040","article-title":"Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms","volume":"26","author":"Chin","year":"2013","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-019-0675-9","article-title":"Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways","volume":"7","author":"Christensen","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110455_bib83","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.2058","article-title":"Enhanced tonic GABAA inhibition in typical absence epilepsy","volume":"15","author":"Cope","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110455_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1042\/BST0380564","article-title":"Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy","volume":"38","author":"Cowan","year":"2010","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110455_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrn811","article-title":"Childhood absence epilepsy: genes, channels, neurons and networks","volume":"3","author":"Crunelli","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110455_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-015-0193-3","article-title":"Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca(++) dysregulation","volume":"3","author":"Decker","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110455_bib20","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1093\/brain\/awaa312","article-title":"Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice","volume":"143","author":"Degiorgis","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13195-019-0518-8","article-title":"Tau and atrophy: domain-specific relationships with cognition","volume":"11","author":"Digma","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2025.110455_bib84","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","article-title":"Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory","volume":"6","author":"F\u00e1","year":"2016","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110455_bib81","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","article-title":"Propagation of tau misfolding from the outside to the inside of a cell","volume":"284","author":"Frost","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib24","first-page":"65","article-title":"Slow wave and rem sleep mechanisms are differently altered in hereditary pick disease associated with the TAU G389R mutation","volume":"143","author":"Gemignani","year":"2005","journal-title":"Arch. Ital. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110455_bib25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/cercor\/bhs105","article-title":"Increased cortical and thalamic excitability in freely moving APPswe\/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease","volume":"23","author":"Gurevicius","year":"2013","journal-title":"Cerebr. Cortex"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110455_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004165","article-title":"Experimentally verified parameter sets for modelling heterogeneous neocortical pyramidal-cell populations","volume":"11","author":"Harrison","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110455_bib27","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0166-19.2019","article-title":"Introduction of tau oligomers into cortical neurons alters action potential dynamics and disrupts synaptic transmission and plasticity. eNeuro","volume":"6","author":"Hill","year":"2019","journal-title":"ENEURO"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib28","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0330-20.2020","article-title":"\u03b1-Synuclein aggregates increase the conductance of substantia nigra dopamine neurons, an effect partly reversed by the KATP channel inhibitor glibenclamide. eNeuro","volume":"8","author":"Hill","year":"2021","journal-title":"ENEURO"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s42003-021-02791-x","article-title":"Truncating tau reveals different pathophysiological actions of oligomers in single neurons","volume":"4","author":"Hill","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuropharm.2025.110455_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbscr.2016.08.002","article-title":"Sleep in Alzheimer's disease - beyond amyloid","volume":"2","author":"Holth","year":"2017","journal-title":"Neurobiol. Sleep Circadian Rhythms"},{"issue":"6429","key":"10.1016\/j.neuropharm.2025.110455_bib31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aav2546","article-title":"The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans","volume":"363","author":"Holth","year":"2019","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110455_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tins.2007.05.007","article-title":"Thalamic synchrony and dynamic regulation of global forebrain oscillations","volume":"30","author":"Huguenard","year":"2007","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110455_bib34","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1523\/JNEUROSCI.14-09-05485.1994","article-title":"Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects","volume":"14","author":"Huguenard","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110455_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.974414","article-title":"The prion-like transmission of tau oligomers via exosomes","volume":"14","author":"Jackson","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110455_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2017.09.014","article-title":"Corticothalamic network dysfunction and Alzheimer's disease","volume":"1702","author":"Jagirdar","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110455_bib37","article-title":"Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy","volume":"5","author":"Ji","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110455_bib82","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41591-024-03400-0","article-title":"Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer\u2019s disease","volume":"31","author":"Islam","year":"2025","journal-title":"Nat Med."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110455_bib39","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1113\/JP271968","article-title":"Intracellular soluble \u03b1-synuclein oligomers reduce pyramidal cell excitability","volume":"594","author":"Kaufmann","year":"2016","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110455_bib40","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1152\/jn.2000.83.5.2542","article-title":"Short-term potentiation of miniature excitatory synaptic currents causes excitation of supraoptic neurons","volume":"83","author":"Kombian","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110455_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroscience.2012.07.005","article-title":"Impaired transmission at corticothalamic excitatory inputs and intrathalamic GABAergic synapses in the ventrobasal thalamus of heterozygous BDNF knockout mice","volume":"222","author":"Laudes","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110455_bib42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2025.110455_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2017.06.006","article-title":"GABA receptors and T-type Ca2+ channels crosstalk in thalamic networks","volume":"136","author":"Leresche","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110455_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archneur.62.3.371","article-title":"Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory","volume":"62","author":"Meeren","year":"2005","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(90)90486-U","article-title":"Thalamic spindles in an isolated and perfused preparation in vitro","volume":"524","author":"M\u00fchlethaler","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110455_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coph.2018.01.012","article-title":"Metabotropic glutamate receptors as drug targets for the treatment of absence epilepsy","volume":"38","author":"Ngomba","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110455_bib49","article-title":"Cellular and pathological functions of tau","volume":"16","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110455_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0165-3806(95)00171-9","article-title":"Development of firing patterns and electrical properties in neurons of the rat ventrobasal thalamus","volume":"91","author":"Perez Velazquez","year":"1996","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110455_bib51","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/cercor\/bhn237","article-title":"Inactivation of the somatosensory cortex prevents paroxysmal oscillations in cortical and related thalamic neurons in a genetic model of absence epilepsy","volume":"19","author":"Polack","year":"2009","journal-title":"Cerebr. Cortex"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110455_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","article-title":"Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson's disease in rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1152\/jn.00667.2002","article-title":"Actions of U-92032, a T-type Ca2+ channel antagonist, support a functional linkage between I(T) and slow intrathalamic rhythms","volume":"89","author":"Porcello","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110455_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2023.102482","article-title":"Intracellular accumulation of tau oligomers in astrocytes and their synaptotoxic action rely on Amyloid Precursor Protein Intracellular Domain-dependent expression of Glypican-4","volume":"227","author":"Puliatti","year":"2023","journal-title":"Prog. Neurobiol."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110455_bib55","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1113\/jphysiol.2007.148957","article-title":"Short-term potentiation of mEPSCs requires N-, P\/Q- and L-type Ca2+ channels and mitochondria in the supraoptic nucleus","volume":"586","author":"Quinlan","year":"2008","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-021-01246-y","article-title":"Synaptic tau: a pathological or physiological phenomenon?","volume":"9","author":"Robbins","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2025.110455_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-981-32-9358-8_11","article-title":"Tau secretion","volume":"1184","author":"Ruan","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110455_bib58","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0006-3495(98)77867-1","article-title":"Optical measurement of presynaptic calcium currents","volume":"74","author":"Sabatini","year":"1998","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00401-024-02749-3","article-title":"Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus","volume":"147","author":"S\u00e1rk\u00e1ny","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110455_bib60","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2353\/ajpath.2006.050840","article-title":"Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy","volume":"168","author":"Spires","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110455_bib61","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1523\/JNEUROSCI.22-13-05374.2002","article-title":"Somatostatin inhibits thalamic network oscillations in vitro: actions on the GABAergic neurons of the reticular nucleus","volume":"22","author":"Sun","year":"2002","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1523\/JNEUROSCI.22-01-00133.2002","article-title":"Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau","volume":"22","author":"Tanemura","year":"2002","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110455_bib63","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1073\/pnas.202205599","article-title":"Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau","volume":"99","author":"Tatebayashi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110455_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2016.11.011","article-title":"Brain imaging evidence of early involvement of subcortical regions in familial and sporadic Alzheimer's disease","volume":"1655","author":"Tentolouris-Piperas","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110455_bib65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","article-title":"Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease","volume":"51","author":"Tracy","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"issue":"121","key":"10.1016\/j.neuropharm.2025.110455_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2025.110455_bib67","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1103\/PhysRev.36.823","article-title":"On the theory of the Brownian motion","volume":"36","author":"Uhlenbeck","year":"1930","journal-title":"Phys. Rev."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110455_bib68","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0896-6273(95)90181-7","article-title":"Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity","volume":"15","author":"Ulrich","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110455_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.614587","article-title":"Absence of uptake and prion-like spreading of alpha-synuclein and tau after intravitreal injection of preformed fibrils","volume":"12","author":"Veys","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110455_bib70","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1007\/s12035-023-03387-8","article-title":"The role of tau proteoforms in Health and disease","volume":"60","author":"Waheed","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110455_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109172","article-title":"Adenosine is released during thalamic oscillations to provide negative feedback control","volume":"216","author":"Wall","year":"2022","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110455_bib72","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1152\/jn.1994.72.4.1993","article-title":"Oscillatory synaptic interactions between ventroposterior and reticular neurons in mouse thalamus in vitro","volume":"72","author":"Warren","year":"1994","journal-title":"J. Neurophysiol."},{"issue":"5530","key":"10.1016\/j.neuropharm.2025.110455_bib73","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1062382","article-title":"Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles","volume":"293","author":"Wittmann","year":"2001","journal-title":"Science."},{"key":"10.1016\/j.neuropharm.2025.110455_bib74","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/ncomms5159","article-title":"Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model","volume":"5","author":"Wu","year":"2014","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110455_bib75","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","article-title":"Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons","volume":"288","author":"Wu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110455_bib76","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110455_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110455_bib78","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1152\/jn.00624.2003","article-title":"Corticothalamic inhibition in the thalamic reticular nucleus","volume":"91","author":"Zhang","year":"2004","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110455_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002470","article-title":"Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice","volume":"22","author":"Zhang","year":"2024","journal-title":"PLoS Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:32:19Z","timestamp":1778142739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":76,"alternative-id":["S0028390825001613"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110455","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110455"}}